Hypercapnic acidosis reduces oxidative reactions in endotoxin-induced lung injury

Anesthesiology

Volumn 113, Issue 1, 2010, Pages 116-125

  Nichol, Alistair D ^a,b   Ocronin, Donall F ^a,c   Naughton, Finola ^a   Hopkins, Natalie ^e   Boylan, John ^d   McLoughlin, Paul ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b MONASH UNIVERSITY   (Australia)

^c MERCY UNIVERSITY HOSPITAL   (Ireland)

^d ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^e DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DIOXIDE; ENDOTOXIN; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE; OXYGEN; RHODAMINE; ENDOTOXIN, ESCHERICHIA COLI;

ACUTE LUNG INJURY; AEROBIC METABOLISM; AIRWAY PRESSURE; ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; HYPERCAPNIA; LUNG HOMOGENATE; LUNG INJURY; MALE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; RAT; RESPIRATORY ACIDOSIS; SPECTROFLUOROMETRY; TIDAL VOLUME; TISSUE INJURY; TRACHEOSTOMY; ANIMAL; CHEMICALLY INDUCED DISORDER; METABOLISM; METHODOLOGY; OXIDATION REDUCTION REACTION; RANDOMIZATION; SPRAGUE DAWLEY RAT;

ACIDOSIS, RESPIRATORY; ACUTE LUNG INJURY; ANIMALS; ENDOTOXINS; HYPERCAPNIA; MALE; OMEGA-N-METHYLARGININE; OXIDATION-REDUCTION; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RESPIRATION, ARTIFICIAL; TIDAL VOLUME;

EID: 77954177556     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3181dfd2fe     Document Type: Article

References (62)

1. Hickling KG, Walsh J, Henderson S, Jackson R: Low mortality rate in adult respiratory distress syndrome using low-volume, pressure-limited ventilation with permissive hypercapnia: A prospective study. Crit Care Med 1994; 22:1568-1578
2. Amato MB, Barbas CS, Medeiros DM, Magaldi RB, Schettino GP, Lorenzi-Filho G, Kairalla RA, Deheinzelin D, Munoz C, Oliveira R, Takagaki TY, Carvalho CR: Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 1998; 338:347-354 (Pubitemid 28083906)
3. Hickling KG, Henderson SJ, Jackson R: Low mortality associated with low volume pressure limited ventilation with permissive hypercapnia in severe adult respiratory distress syndrome. Intensive Care Med 1990; 16:372-377
4. Laffey JG, Jankov RP, Engelberts D, Tanswell AK, Post M, Lindsay T, Mullen JB, Romaschin A, Stephens D, McKerlie C, Kavanagh BP: Effects of therapeutic hypercapnia on mesenteric ischemia-reperfusion injury. Am J Respir Crit Care Med 2003; 168:1383-1390
5. Laffey JG, Honan D, Hopkins N, Hyvelin JM, Boylan JF, McLoughlin P: Hypercapnic acidosis attenuates endotoxin-induced acute lung injury. Am J Respir Crit Care Med 2004; 169:46-56
6. Broccard AF, Hotchkiss JR, Vannay C, Markert M, Sauty A, Feihl F, Schaller MD: Protective effects of hypercapnic acidosis on ventilator-induced lung injury. Am J Respir Crit Care Med 2001; 164:802-806
7. Sinclair SE, Kregenow DA, Lamm WJ, Starr IR, Chi EY, Hlastala MP: Hypercapnic acidosis is protective in an in vivo model of ventilator-induced lung injury. Am J Respir Crit Care Med 2002; 166:403-408
8. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000; 342:1301-1308
9. Kregenow DA, Rubenfeld GD, Hudson LD, Swenson ER: Hypercapnic acidosis and mortality in acute lung injury. Crit Care Med 2006; 34:1-7
10. Laffey JG, Tanaka M, Engelberts D, Luo X, Yuan S, Tanswell AK, Post M, Lindsay T, Kavanagh BP: Therapeutic hypercapnia reduces pulmonary and systemic injury following in vivo lung reperfusion. Am J Respir Crit Care Med 2000; 162:2287-2294
11. Takeshita K, Suzuki Y, Nishio K, Takeuchi O, Toda K, Kudo H, Miyao N, Ishii M, Sato N, Naoki K, Aoki T, Suzuki K, Hiraoka R, Yamaguchi K: Hypercapnic acidosis attenuates endotoxin-induced nuclear factor-B activation. Am J Respir Cell Mol Biol 2003; 29:124-32
12. 2 modulates intracellular pH, intracellular oxidant generation, and interleukin-8 secretion in human neutrophils. J Leukoc Biol 2002; 71:603-610
13. Barth A, Bauer R, Gedrange T, Walter B, Klinger W, Zwie-ner U: Influence of hypoxia and hypoxia/hypercapnia upon brain and blood peroxidative and glutathione status in normal weight and growth-restricted newborn piglets. Exp Toxicol Pathol 1998; 50:402-410
14. Fialkow L, Wang Y, Downey GP: Reactive oxygen and nitrogen species as signaling molecules regulating neutrophil function. Free Radic Biol Med 2007; 42:153-164
15. Abraham E: Neutrophils and acute lung injury. Crit Care Med 2003; 31:S195-9
16. Zhang H, Slutsky AS, Vincent JL: Oxygen free radicals in ARDS, septic shock and organ dysfunction. Intensive Care Med 2000; 26:474-476
17. Lang JD, McArdle PJ, O'Reilly PJ, Matalon S: Oxidant-antioxidant balance in acute lung injury. Chest 2002; 122: 314S-20S
18. Pacher P, Beckman JS, Liaudet L: Nitric oxide and per-oxynitrite in health and disease. Physiol Rev 2007; 87:315-424
19. Berlett BS, Levine RL, Stadtman ER: Carbon dioxide stimulates peroxynitrite-mediated nitration of tyrosine residues and inhibits oxidation of methionine residues of glutamine synthetase: Both modifications mimic effects of adenylation. Proc Natl Acad Sci USA1998; 95:2784-2789
20. Zhu S, Basiouny KF, Crow JP, Matalon S: Carbon dioxide enhances nitration of surfactant protein A by activated alveolar macrophages. Am J Physiol Lung Cell Mol Physiol 2000; 278:L1025-31
21. Beckman JS, Koppenol WH: Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly. Am J Physiol 1996; 271:C1424-37
22. Zhao YY, Zhao YD, Mirza MK, Huang JH, Potula HH, Vogel SM, Brovkovych V, Yuan JX, Wharton J, Malik AB: Persistent eNOS activation secondary to caveolin-1 deficiency induces pulmonary hypertension in mice and humans through PKG nitration. J Clin Invest 2009; 119:2009-2018
23. van der Vliet A, Eiserich JP, Shigenaga MK, Cross CE: Reactive nitrogen species and tyrosine nitration in the respiratory tract: Epiphenomena or a pathobiologic mechanism of disease? Am J Respir Crit Care Med 1999; 160:1-9
24. Kavanagh BP, Laffey JG: Hypercapnia: Permissive and therapeutic. Minerva Anestesiol 2006; 72:567-576
25. Kantores C, McNamara PJ, Teixeira L, Engelberts D, Mur-thy P, Kavanagh BP, Jankov RP: Therapeutic hypercapnia prevents chronic hypoxia-induced pulmonary hypertension in the newborn rat. Am J Physiol Lung Cell Mol Physiol 2006; 291:L912-22
26. Laffey JG, Engelberts D, Kavanagh BP: Buffering hypercapnic acidosis worsens acute lung injury. Am J Respir Crit Care Med 2000; 161:141-146
27. Cuzzocrea S, Misko TP, Costantino G, Mazzon E, Micali A, Caputi AP, Macarthur H, Salvemini D: Beneficial effects of peroxynitrite decomposition catalyst in a rat model of splanchnic artery occlusion and reperfusion. FASEB J 2000; 14:1061-1072 (Pubitemid 30350387)
28. Szabo C, Salzman AL, Ischiropoulos H: Peroxynitrite-mediated oxidation of dihydrorhodamine 123 occurs in early stages of endotoxic and hemorrhagic shock and ischemia-reperfusion injury. FEBS Lett 1995; 372:229-232
29. Cadogan E, Hopkins N, Giles S, Bannigan JG, Moynihan J, McLoughlin P: Enhanced expression of inducible nitric oxide synthase without vasodilator effect in chronically infected lungs. Am J Physiol 1999; 277:L616-27
30. Howell K, Hopkins N, McLoughlin P: Combined confocal microscopy and stereology: A highly efficient and unbiased approach to quantitative structural measurement in tissues. Exp Physiol 2002; 87:747-756
31. Hopkins N, Gunning Y, O'Croinin DF, LaffeyJG, McLoughlin P: Anti-inflammatory effect of augmented nitric oxide production in chronic lung infection. J Pathol 2006; 209: 198-205
32. O'Croinin DF, Hopkins NO, Moore MM, Boylan JF, McLoughlin P, Laffey JG: Hypercapnic acidosis does not modulate the severity of bacterial pneumonia-induced lung injury. Crit Care Med 2005; 33:2606-2612
33. O'Croinin DF, Nichol AD, Hopkins N, Boylan J, O'Brien S, O'Connor C, LaffeyJG, McLoughlin P: Sustained hypercapnic acidosis during pulmonary infection increases bacteria and worsens lung injury. Crit Care Med 2008; 37:2128-2135
34. Abraham E, Carmody A, Shenkar R, Arcaroli J: Neutrophils as early immunologic effectors in hemorrhage-or endo-toxemia-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol 2000; 279:L1137-45
35. Eiserich J, Hristova M, Cross C, Jones A, Freeman B, Hal-liwell B, van der Vliet A: Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 1998; 22:393-397
36. Fialkow L, Fochesatto FL, Bozzetti MC, Milani AR, Ro-drigues FEM, Ladniuk RM, Pierozan P, de Moura RM, Prolla JC, Vachon E, Downey GP: Neutrophil apoptosis: A marker of disease severity in sepsis and sepsis-induced acute respiratory distress syndrome. Crit Care 2006; 10:R155
37. Tarpey MM, Fridovich I: Methods of detection of vascular reactive species: Nitric oxide, superoxide, hydrogen peroxide, and peroxynitrite. Circ Res 2001; 89:224-236
38. CrowJP: Dichlorodihydrofluorescein and dihydrorhodam-ine 123 are sensitive indicators of peroxynitrite in vitro: Implications for intracellular measurement of reactive nitrogen and oxygen species. Nitric Oxide 1997; 1:145-157
39. 2 in cultured endothelial cells. Arch Biochem Biophys 1993; 302:348-355
40. Gray GA, Schott C, Julou-Schaeffer G, Fleming I, Parratt JR, Stoclet JC: The effect of inhibitors of the L-arginine/nitric oxide pathway on endotoxin-induced loss of vascular responsiveness in anaesthetized rats. Br J Pharmacol 1991; 103:1218-1224
41. Rees DD, Palmer RM, Schulz R, Hodson HF, Moncada S: Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 1990; 101:746-752 (Pubitemid 20357206)
42. Roberts LJ, Morrow JD: Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 2000; 28:505-513
43. Johnson LV, Walsh ML, Chen LB: Localization of mitochondria in living cells with rhodamine 123. Proc Natl Acad Sci USA 1980; 77:990-994
44. Cantin A, Woods DE: Protection by antibiotics against myeloperoxidase-dependent cytotoxicity to lung epithelial cells in vitro. J Clin Invest 1993; 91:38-45
45. Klebanoff SJ: Myeloperoxidase: Friend and foe. J Leukoc Biol 2005; 77:598-625
46. Virag L, Szabo E, Gergely P, Szabo C: Peroxynitrite-induced cytotoxicity: Mechanism and opportunities for intervention. Toxicol Lett 2003; 140-141:113-124
47. Hurst JK: Whence nitrotyrosine? J Clin Invest 2002; 109: 1287-1289
48. Gaut JP, Byun J, Tran HD, Lauber WM, Carroll JA, Hotch-kiss RS, Belaaouaj A, Heinecke JW: Myeloperoxidase produces nitrating oxidants in vivo. J Clin Invest 2002; 109: 1311-1319
49. Hataishi R, Kobayashi H, Takahashi Y, Hirano S, Zapol WM, Jones RC: Myeloperoxidase-associated tyrosine nitration after intratracheal administration of lipopolysaccharide in rats. ANESTHESIOLOGY 2002; 97:887-895
50. Brennan ML, Wu W, Fu X, Shen Z, Song W, Frost H, Vadseth C, Narine L, Lenkiewicz E, Borchers MT, Lusis AJ, Lee JJ, Lee NA, Abu-Soud HM, Ischiropoulos H, Hazen SL: A tale of two controversies: Defining both the role of peroxidases in nitrotyrosine formation in vivo using eosin-ophil peroxidase and myeloperoxidase-deficient mice, and the nature of peroxidase-generated reactive nitrogen species. J Biol Chem 2002; 277:17415-17427
51. Honda K, Kobayashi H, Hataishi R, Hirano S, Fukuyama N, Nakazawa H, Tomita T: Inhaled nitric oxide reduces ty-rosine nitration after lipopolysaccharide instillation into lungs of rats. Am J Respir Crit Care Med 1999; 160:678-688
52. Kooy NW, Royall JA, Ye YZ, Kelly DR, Beckman JS: Evidence for in vivo peroxynitrite production in human acute lung injury. Am J Respir Crit Care Med 1995; 151:1250-1254
53. Imai Y, Kuba K, Neely GG, Yaghubian-Malhami R, Perk-mann T, van Loo G, Ermolaeva M, Veldhuizen R, Leung YH, Wang H, Liu H, Sun Y, Pasparakis M, Kopf M, Mech C, Bavari S, Peiris JS, Slutsky AS, Akira S, Hultqvist M, Holm-dahl R, Nicholls J, Jiang C, Binder CJ, Penninger JM: Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 2008; 133:235-249
54. Liaw WJ, Chen TH, Lai ZZ, Chen SJ, Chen A, Tzao C, Wu JY, Wu CC: Effects of a membrane-permeable radical scavenger, Tempol, on intraperitoneal sepsis-induced organ injury in rats. Shock 2005; 23:88-96
55. Ritter C, da Cunha AA, Echer IC, Andrades M, Reinke A, Lucchiari N, Rocha J, Streck EL, Menna-Barreto S, Moreira JC, Dal-Pizzol F: Effects of N-acetylcysteine plus deferox-amine in lipopolysaccharide-induced acute lung injury in the rat. Crit Care Med 2006; 34:471-477
56. Shi XL, Shi ZH, Huang H, Zhu HG, Zhou P, Ju D: Therapeutic effect of recombinant human catalase on H1N1 influenza-induced pneumonia in mice. Inflammation 2010; 33:166-172
57. Baldwin SR, Simon RH, Grum CM, Ketai LH, Boxer LA, Devall LJ: Oxidant activity in expired breath of patients with adult respiratory distress syndrome. Lancet 1986; 1:11-14
58. Bowler RP, Velsor LW, Duda B, Chan ED, Abraham E, Ware LB, Matthay MA, Day BJ: Pulmonary edema fluid antioxi-dants are depressed in acute lung injury. Crit Care Med 2003; 31:2309-2315
59. Carpenter CT, Price PV, Christman BW: Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDS. Chest 1998; 114:1653-1659
60. Kumar KV, Rao SM, Gayani R, Mohan IK, Naidu MU: Oxidant stress and essential fatty acids in patients with risk and established ARDS. Clin Chim Acta 2000; 298:111-120
61. Sznajder JI, Fraiman A, Hall JB, Sanders W, Schmidt G, Crawford G, Nahum A, Factor P, Wood LD: Increased hydrogen peroxide in the expired breath of patients with acute hypoxemic respiratory failure. Chest 1989; 96:606-612
62. Laffey JG, O'Croinin D, McLoughlin P, Kavanagh BP: Permissive hypercapnia\role in protective lung ventilatory strategies. Intensive Care Med 2004; 30:347-356